Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × abiraterone × 30 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 5 Neoplasm Metastasis 2 Salivary Gland Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Prostate Cancer Metastatic Disease 1 PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy 1 Ovarian Neoplasms 1 Metastatic Hormone-sensitive Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Bulbo-Spinal Atrophy, X-Linked 1 Bites and Stings 1 Advanced Solid Tumor 1 Adenocarcinoma 1

Interventions

Bevacizumab 2 selpercatinib 1 selinexor 1 repotrectinib 1 relatlimab 1 relacorilant 1 pembrolizumab 1 olaparib 1 elacestrant 1 durvalumab 1 darolutamide 1 abemaciclib 1 Sunitinib 1 RAD1901 1 Pluvicto 1 Pemetrexed 1 Nivolumab 1 Immunotherapy 1 Drug Therapy 1 Cisplatin 1 Cetuximab 1 Carboplatin 1 Abiraterone Acetate 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1 130-nm albumin-bound paclitaxel 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡